The association of HPV-16 seropositivity and natural immunity to reinfection: insights from compartmental models.

Seroreactivity, processes of seroconversion and seroreversion, in the context of HPV infection has been investigated in numerous studies. However, the data resulting from these studies are usually not accounted for in mathematical transmission models of various HPV types due to gaps in our understanding of the nature of seroreactivity and its implications for HPV natural history.
In this study we selected a number of simple but plausible compartmental transmission models of HPV-16, differing in assumptions regarding the relation between seropositivity and immunity, and attempted to calibrate them to Australian HPV seroprevalence data for females and males, as well as DNA prevalence data for females, using a Bayesian model comparison procedure. We ranked the models according to both their simplicity and ability to be fitted to the data.
Our results demonstrate that models with seroreversion where seropositivity indicates only a partial or very short-term full protection against re-infection generate age-specific HPV DNA prevalence most consistent with the observed data when compared with other models.
Models supporting the notion that seropositive individuals are fully immune to reinfection demonstrated consistently inferior fits to the data than other models making no such assumption.
AuthorsIgor A Korostil, Suzanne M Garland, Matthew G Law, David G Regan
JournalBMC infectious diseases (BMC Infect Dis) Vol. 13 Pg. 83 ( 2013) ISSN: 1471-2334 [Electronic] England
PMID23402400 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
  • Bayes Theorem
  • Female
  • Human papillomavirus 16 (immunology)
  • Humans
  • Male
  • Models, Immunological
  • Papillomavirus Infections (immunology, transmission, virology)
  • Seroepidemiologic Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: